API reference
Indacaterol
- CAS number
- 312753-06-3
- Molecular formula
- C24H28N2O3
- Molecular weight
- 392.5 g/mol
About this molecule
Indacaterol is a novel, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (EMA) on 30 November 2009 and by the FDA on 1 July 2011. It is marketed in Europe as Onbrez and in America as Arcapta Neohaler. Indacaterol is provided as its maleate salt form. Indacaterol is also a chiral molecule but only the pure R-enantiomer is dispensed.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one
- InChIKey
- QZZUEBNBZAPZLX-QFIPXVFZSA-N
- SMILES
- CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC
- PubChem CID
- 6918554
Also known as
Indacaterol · Onbrez · QAB-149 · QAB149 · Indacterol · QAB 149 · indacaterolum · QABI49
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.